Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma
The incidence of irAEs in this cohort is lower than reported in controlled trials, withouut impact on survival outcomes. Education and early recognition are crucial to ensure that these events are identified and addressed.
Authors
- Adriana Varón (ORCID: https://orcid.org/0000-0002-8294-2194)
- Alexandre de Araújo (ORCID: https://orcid.org/0000-0002-4128-6936)
- Jaime Poníachik (ORCID: https://orcid.org/0000-0001-7958-3357)
- Juan Ignacio Marín (ORCID: https://orcid.org/0000-0001-6954-8910)
- Ezequiel Demirdjian
- Leonardo Gomes da Fonseca (ORCID: https://orcid.org/0000-0002-0216-3618)
- J. Flórez (ORCID: https://orcid.org/0000-0002-9034-6464)
- Fernando Bessone (ORCID: https://orcid.org/0000-0002-8569-8123)
- Manuel Mendizábal (ORCID: https://orcid.org/0000-0002-7026-9908)
- Federico Piñero (ORCID: https://orcid.org/0000-0002-9528-2279)
- Ezequiel Ridruejo (ORCID: https://orcid.org/0000-0002-3321-0683)
- M.D. Villa
- Sebastián Marciano (ORCID: https://orcid.org/0000-0002-7983-1450)
- Margarita Anders (ORCID: https://orcid.org/0000-0002-2238-5322)
- Pablo Caballini
- Daniela Perez
- Carla Bermúdez (ORCID: https://orcid.org/0000-0003-0082-9006)
- Oscar Beltrán (ORCID: https://orcid.org/0000-0003-2800-8496)
- Jorge Rodríguez (ORCID: https://orcid.org/0000-0002-6790-7729)
- Federico Orozco
Institutions
- University of Mendoza (AR)
- Universidade Federal do Rio Grande do Sul (BR)
- Hospital Italiano de Buenos Aires (AR)
- Instituto do Câncer do Estado de São Paulo (BR)
- Hospital de Clínicas de Porto Alegre (BR)
- Hospital Universitario Austral (AR)
- Hospital Pablo Tobon Uribe (CO)
- Hospital Provincial de Rosario (AR)
- Hospital Clínico de la Universidad de Chile (CL)
- Fundación Santa Fe de Bogotá (CO)
- Institute of Cardiology (CO)
- Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (AR)
- Hospital Alemán (AR)
Publication Details
- Journal
- Oncotarget
- Published
- 2025-05-19
- DOI
- https://doi.org/10.18632/oncotarget.28721
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32